NovaBay Pharmaceuticals Inc (NBY) — Cash Flow Reinvestment Rate
NovaBay Pharmaceuticals Inc (NBY) has a Cash Flow Reinvestment Rate of 0.26x as of September 2017, reinvesting $73.00K (capex $73.00K ) from operating cash flow of $281.00K. Explore capital reinvestment ratio of NovaBay Pharmaceuticals Inc to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
NovaBay Pharmaceuticals Inc Cash Flow Reinvestment Rate (2006–2010)
Historical reinvestment intensity for NovaBay Pharmaceuticals Inc across 2 annual periods. Also explore NovaBay Pharmaceuticals Inc assets under control for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for NovaBay Pharmaceuticals Inc (2006–2010)
Year-by-year capital reinvestment analysis for NovaBay Pharmaceuticals Inc. For live market cap and broader valuation context, see how much is NovaBay Pharmaceuticals Inc worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2010 | 0.10x | $203.00K | $2.03 Million | $203.00K | ▲ +31.2% |
| 2006 | 0.08x | $362.00K | $4.74 Million | $362.00K | — |